Erratum: Mechanism of early dissemination and metastasis in Her2+ mammary cancer (Nature (2016) 540 (588-592) DOI: 10.1038/nature20609);Mechanism of early dissemination and metastasis in Her2+ mammary cancer

Nature

Volumn 540, Issue 7634, 2016, Pages 588-592

  Harper, Kathryn L ^a   Sosa, Maria Soledad ^a   Entenberg, David ^b   Hosseini, Hedayatollah ^c   Cheung, Julie F ^a   Nobre, Rita ^a   Avivar Valderas, Alvaro ^a   Nagi, Chandandaneep ^a   Girnius, Nomeda ^d   Davis, Roger J ^d   Farias, Eduardo F ^a   Condeelis, John ^b   Klein, Christoph A ^a,c,e   Aguirre Ghiso, Julio A ^a  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^b ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^c UNIVERSITY OF REGENSBURG   (Germany)

^d UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

^e Project Group Personalized Tumour Therapy Fraunhofer Institute of Experimental Medicine and Toxicology   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR 2;

ABNORMALITY; CANCER; DORMANCY; GENE EXPRESSION; INHIBITION; PHENOTYPE; RODENT; SUBPOPULATION; TUMOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BREAST CANCER; BREAST EPITHELIUM CELL; CONTROLLED STUDY; EPITHELIAL MESENCHYMAL TRANSITION; METASTASIS; MOUSE; NONHUMAN; PRIORITY JOURNAL;

MUS;

EID: 85014867897     PISSN: 00280836     EISSN: 14764687     Source Type: Journal    
DOI: 10.1038/nature24666     Document Type: Erratum

References (35)

1. Sosa, M. S., Bragado, P., Aguirre-Ghiso, J. A. Mechanisms of disseminated cancer cell dormancy: An awakening field. Nat. Rev. Cancer 14, 611-622 (2014).
2. Hanahan, D., Weinberg, R. A. Hallmarks of cancer: The next generation. Cell 144, 646-674 (2011).
3. Schardt, J. A., et al. Genomic analysis of single cytokeratin-positive cells from bone marrow reveals early mutational events in breast cancer. Cancer Cell 8, 227-239 (2005).
4. Klein, C. A., et al. Comparative genomic hybridization, loss of heterozygosity, DNA sequence analysis of single cells. Proc. Natl Acad. Sci. USA 96, 4494-4499 (1999).
5. Schmidt-Kittler, O., et al. From latent disseminated cells to overt metastasis: Genetic analysis of systemic breast cancer progression. Proc. Natl Acad. Sci. USA 100, 7737-7742 (2003).
6. Rhim, A. D., et al. EMT and dissemination precede pancreatic tumor formation. Cell 148, 349-361 (2012).
7. Eyles, J., et al. Tumor cells disseminate early, but immunosurveillance limits metastatic outgrowth, in a mouse model of melanoma. J. Clin. Invest. 120, 2030-2039 (2010).
8. Hüsemann, Y., et al. Systemic spread is an early step in breast cancer. Cancer Cell 13, 58-68 (2008).
9. Sänger, N., et al. Disseminated tumor cells in the bone marrow of patients with ductal carcinoma in situ. Int. J. Cancer 129, 2522-2526 (2011).
10. Wen, H. C., et al. p38 signaling induces anoikis and lumen formation during mammary morphogenesis. Sci. Signal. 4, ra34 (2011).
11. Cardiff, R. D. Validity of mouse mammary tumour models for human breast cancer: Comparative pathology. Microsc. Res. Tech. 52, 224-230 (2001).
12. Lu, J., et al. 14-3-3 cooperates with ErbB2 to promote ductal carcinoma in situ progression to invasive breast cancer by inducing epithelial-mesenchymal transition. Cancer Cell 16, 195-207 (2009).
13. Strippoli, R., et al. p38 maintains E-cadherin expression by modulating TAK1-NF-B during epithelial-to-mesenchymal transition. J. Cell Sci. 123, 4321-4331 (2010).
14. Entenberg, D., et al. Setup and use of a two-laser multiphoton microscope for multichannel intravital fluorescence imaging. Nat. Protocols 6, 1500-1520 (2011).
15. Malladi, S., et al. Metastatic latency and immune evasion through autocrine inhibition of WNT. Cell 165, 45-60 (2016).
16. Leung, J. Y., et al. Activation of AXIN2 expression by-catenin-T cell factor. A feedback repressor pathway regulating Wnt signaling. J. Biol. Chem. 277, 21657-21665 (2002).
17. Grumolato, L., et al. Canonical and noncanonical Wnts use a common mechanism to activate completely unrelated coreceptors. Genes Dev. 24, 2517-2530 (2010).
18. Nieto, M. A., Huang, R. Y., Jackson, R. A., Thiery, J. P. Emt: 2016. Cell 166, 21-45 (2016).
19. Bragado, P., et al. TGF-2 dictates disseminated tumour cell fate in target organs through TGF-RIII and p38/signalling. Nat. Cell Biol. 15, 1351-1361 (2013).
20. Brisken, C., et al. Essential function of Wnt-4 in mammary gland development downstream of progesterone signaling. Genes Dev. 14, 650-654 (2000).
21. Rhim, A. D., et al. Detection of circulating pancreas epithelial cells in patients with pancreatic cystic lesions. Gastroenterology 146, 647-651 (2014).
22. Ocanã, O. H., et al. Metastatic colonization requires the repression of the epithelial-mesenchymal transition inducer Prrx1. Cancer Cell 22, 709-724 (2012).
23. Brabletz, T. To differentiate or not-routes towards metastasis. Nat. Rev. Cancer 12, 425-436 (2012).
24. Schmidt, J. M., et al. Stem-cell-like properties and epithelial plasticity arise as stable traits after transient Twist1 activation. Cell Reports 10, 131-139 (2015).
25. Fischer, K. R., et al. Epithelial-to-mesenchymal transition is not required for lung metastasis but contributes to chemoresistance. Nature 527, 472-476 (2015).
26. Hui, L., et al. p38 suppresses normal and cancer cell proliferation by antagonizing the JNK-c-Jun pathway. Nat. Genet. 39, 741-749 (2007).
27. Gozdecka, M., et al. JNK suppresses tumor formation via a gene-expression program mediated by ATF2. Cell Reports 9, 1361-1374 (2014).
28. Bhoumik, A., et al. Suppressor role of activating transcription factor 2 (ATF2) in skin cancer. Proc. Natl Acad. Sci. USA 105, 1674-1679 (2008).
29. Fizazi, K., et al. Cancers of unknown primary site: ESMO clinical practice guidelines for diagnosis, treatment and follow-up. Annals Oncol. 26, v133-v138 (2015).
30. Narod, S. A., Iqbal, J., Giannakeas, V., Sopik, V., Sun, P. Breast cancer mortality after a diagnosis of ductal carcinoma in situ. JAMA Oncol. 1, 888-896 (2015).
31. Hosseini, H., et al. Early dissemination seeds metastasis in breast cancer. Nature http://dx.doi.org/10.1038/nature20785 (2016).
32. Debnath, J., Muthuswarmy, S. K., Brugge, J. S. Morphogenesis and oncogenesis of MCF-10A mammary epithelial acini grown in threedimensional basement membrane cultures. Methods 3, 256-268 (2013).
33. Debnath, J., Brugge, J. S. Modelling glandular epithelial cancers in three-dimensional cultures. Nat. Rev. Cancer 5, 675-688 (2015).
34. Schneider, C. A., Rasband, W. S., Eliceiri, K. W. NIH Image to ImageJ: 25 years of image analysis. Nat. Methods 9, 671-675 (2012).
35. Thévenaz, P., Ruttimann, U. E., Unser M. A pyramid approach to subpixel registration based on intensity. IEEE Trans. Image Process. 7, 27-41 (1998).